Print

MEDA: Astepro Patent Granted  
12/6/2011 6:49:21 AM

GĂ–TEBORG, Sweden--(BUSINESS WIRE)--Regulatory News:

The United States Patent and Trademark Office (USPTO) today issued a patent related to Astepro (azelastine) nasal spray. This patent will be listed in the FDA's Approved Drug Products List (the Orange Book). The Astepro patent is valid until 2028.

//-->